Journal Watch 14/09/2022Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events2 hours ago